中药板块10月30日跌0.79%，步长制药领跌，主力资金净流出7.3亿元

Market Overview - The Chinese traditional medicine sector experienced a decline of 0.79% on October 30, with Bichang Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the traditional medicine sector included: - Qidi Pharmaceutical: Closed at 12.58, up 2.61% with a trading volume of 139,600 shares and a turnover of 174 million yuan [1] - Qianjin Pharmaceutical: Closed at 10.56, up 1.34% with a trading volume of 92,400 shares and a turnover of 98.13 million yuan [1] - Wanbangde: Closed at 15.31, up 1.06% with a trading volume of 213,800 shares and a turnover of 329 million yuan [1] - Conversely, Bichang Pharmaceutical saw a significant decline, closing at 17.08, down 5.64% with a trading volume of 227,800 shares and a turnover of 396 million yuan [2] Capital Flow - The traditional medicine sector experienced a net outflow of 730 million yuan from institutional investors, while retail investors saw a net inflow of 495 million yuan [2] - The capital flow for specific stocks showed: - Wanbangde had a net inflow of 17.93 million yuan from institutional investors, but a net outflow of 22.02 million yuan from retail investors [3] - Qidi Pharmaceutical had a net inflow of 12.11 million yuan from institutional investors, with net outflows from both retail and speculative investors [3]